What is Cytek Biosciences, Inc.'s net margin?

Cytek Biosciences, Inc. (CTKB) reported net margin of -36.2% in Q1 2026.

What is the long-term trend for Cytek Biosciences, Inc.'s net margin?

Over 2 years (2020 to 2025), Cytek Biosciences, Inc.'s net margin has grown at a 25.7% compound annual growth rate (CAGR), from 20.9% to -33%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Cytek Biosciences, Inc. CTKB Net margin

Net margin at other companies

Becton, Dickinson and CompanyBDX

5.3%-2.1pp

Thermo Fisher ScientificTMO

15.2%+1.0pp

DanaherDHR

14.9%-0.9pp

Fulgent Genetics, Inc.FLGT

-23%+43.3pp

10x Genomics, Inc.TXG

-3.5%-1.6pp

TEC

Bio-TechneTECH

10.9%-6.7pp

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

net income/total revenue=-36.2%

Based on trailing twelve months.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s net margin?: Cytek Biosciences, Inc. (CTKB) reported net margin of -36.2% in Q1 2026.
What is the long-term trend for Cytek Biosciences, Inc.'s net margin?: Over 2 years (2020 to 2025), Cytek Biosciences, Inc.'s net margin has grown at a 25.7% compound annual growth rate (CAGR), from 20.9% to -33%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.